



CeGaT’s Exome Sequencing identifies the cause of a rare syndrom
CeGaT successfully clarified the cause for a patient's disease…


CeGaT participates in pancreatic cancer research
CeGaT GmbH has joined a scientific research consortium of leading…


CeGaT celebrates roofing ceremony
Seven months after the ground-breaking ceremony CeGaT celebrated…



CeGaT extends Diagnostic Panel “Neurodegenerative Diseases”
CeGaT extends on their Diagnostic Panels the spectrum of Neurodegenerative…


CeGaT is “Entrepreneur of the year” 2013 Award winner
CeGaT is winner at the Ernst & Young competition "Entrepreneur…


CeGaT launches 21 subpanels for Kidney Diseases
CeGaT has developed new subpanels for comprehensive analysis…


GenomeWeb interview with Saskia Biskup
Today GenomeWeb published a long interview with Saskia Biskup.…


Update on Diagnostic Panels
CeGaT has updated its Diagnostic Panels by adding new genes to…
Genetic Diagnostics
Research & Pharma Solutions


CeGaT is a provider of genetic diagnostics and NGS services. The company is based in Tübingen, Germany and is accredited according to CAP, CLIA, DIN EN ISO 15189 and DIN EN ISO 17025.